Keyphrases
Breast Cancer Tissues
16%
Commercial Real-time PCR
16%
Detection in Liquids
16%
Diagnostic Results
16%
DNA Fragments
16%
False-negative Results
16%
Germany
16%
HER2 Breast Cancer
100%
High Failure Rate
16%
Hotspot mutation
16%
Interlaboratory Comparison
16%
Large Fragment
16%
Liquid Biopsy
100%
Liquid Tissues
100%
Molecular Alterations
16%
Molecular Diagnostics
16%
Mutation Analysis
16%
Mutation Detection
66%
Optimal Treatment
16%
PIK3CA
16%
PIK3CA mutation
100%
Precise Detection
16%
Precision Oncology
16%
Proficiency Testing
100%
Real-time PCR Assay
16%
Reliable Detection
16%
Ring Trial
50%
Sanger Sequencing
33%
Therapeutic Target
16%
Tissue Biopsy
16%
Tissue Sampling
33%
Medicine and Dentistry
Biopsy Technique
25%
Breast Cancer
100%
Cancer Tissue
25%
DNA Fragment
25%
False Negative Result
25%
Liquid Biopsy
100%
Molecular Diagnosis
25%
Next Generation Sequencing
75%
Precision Oncology
25%
Real Time Polymerase Chain Reaction
25%
Sanger Sequencing
50%
Nursing and Health Professions
Biopsy Technique
25%
Breast Cancer
100%
Dideoxynucleotide Sequencing
50%
DNA Fragment
25%
False Negative Result
25%
Liquid Biopsy
100%
Molecular Diagnosis
25%
Next-Generation Sequencing
75%
Real Time Polymerase Chain Reaction
25%
Reference Value
25%
Immunology and Microbiology
Cancer Tissue
33%
Dideoxynucleotide Sequencing
66%
Next Generation Sequencing
100%
Real Time Polymerase Chain Reaction
33%
Reference Value
33%
Biochemistry, Genetics and Molecular Biology
Dideoxynucleotide Sequencing
66%
Next Generation Sequencing
100%
Real-Time Polymerase Chain Reaction
33%
Reference Value
33%
Food Science
Next Generation Sequencing
100%
Real-Time Polymerase Chain Reaction
33%
Sanger Sequencing
66%